4 Use Cases for Augmenting Primary Data with Synthetic Data in Pharma Market Research

4 Use Cases for Augmenting Primary Data with Synthetic Data in Pharma Market Research

Synthetic data is not new to market research, and the healthcare insights industry is starting to get friendly with the idea of conversational AI and digital twins. At the forefront of this transformation is synthetic data—an innovative tool that is redefining how market research is conducted across industries. But what exactly is all the buzz about?

Synthetic data is like a best friend to traditional market research—a supportive companion that doesn’t overshadow but enhances the insight-gathering process. It’s a game-changer for pharma and healthcare brands seeking new ways to deepen their understanding of patients, HCPs, payors, and market sentiments. 

Types of Synthetic Data

The diversity within synthetic data is vast, with four main types emerging as particularly useful in market research:

  1. Persona-Based: Imagine fictional profiles that mirror real data patterns—great for hypothesis development and internal training. 
  2. Boosted Samples: Synthesize respondents to fill gaps, balancing representation across hard-to-reach groups.
  3. Pure Silicon Samples: These fully synthetic datasets mirror population characteristics, ideal for internal research where privacy is crucial.
  4. Digital Twins: Digital twins model individual behaviors over time, assisting in behavioral forecasting and market simulations.

Use Cases for Synthetic Data

Synthetic data can shine in numerous areas, amplifying market research’s effectiveness in ways traditional methods may fall short:

  • Hypothesis Generation: Ideal for testing the waters on new drug formulations or devices before diving into costly primary data collection.
  • Early-Stage Testing: Streamlining initial concept tests without the baggage of extensive primary data collection.
  • Dataset Augmentation: When privacy or ethics limit access to patient data, synthetic data steps in, enhancing epidemiological study contexts.
  • Reducing Respondent Burden: Particularly in sensitive areas like mental health, synthetic data lessens the load on actual patient involvement, enabling comprehensive insights with fewer ethical complications.

Navigating the Challenges of Synthetic Data

Like any innovative tool, synthetic data is not without its skeptics and challenges. Synthetic data’s simulations may lack real-world unpredictability. However, integrating clinical, demographic, and lifestyle variables offers a more holistic simulation, capturing the essence of patient behaviors. Historical confirmation bias may be another issue, but periodical updates to models align them with the latest medical advancements, minimizing bias and ensuring relevance. By incorporating real-time data inputs—from electronic health records to wearable devices—synthetic data models can become timely and responsive to emerging health trends.

And while synthetic data may fall short of predicting new disease outbreaks, it simulates various scenarios, allowing the healthcare industry to prepare for the unexpected.

The Final Verdict: Pragmatism Meets Idealism

Synthetic data is no cure-all; rather, it’s a potent augmentation to traditional primary research. When used judiciously, it complements primary data rather than replacing it, filling in the gaps, and speeding up the research process. It invites a pragmatic approach where market researchers can confidently navigate complexities and make informed decisions.

Pragmatism vs. Idealism: Synthetic Data in Market Research

Get your copy of our cheat sheet to learn about common issues, training needs, and specific examples for each type of synthetic data.

As the industry marches toward the future, synthetic data offers a balanced path forward, empowering researchers to leverage the full potential of emerging technologies while maintaining a human touch. The revolution is here—will you join the ride?

 

Blogs & News

Read More
Read More

Patient Voice Isn’t Optional, It’s the Future of RWE

Real-world evidence (RWE) is only as meaningful as the perspectives it includes. While healthcare…

Read More
Read More

Beyond the Hype: How Digital Twins Are Transforming Market Research

Digital twins are reshaping the way we generate insights across industries. In this webinar, we…

Read More
Read More

5 Takeaways from an Intellus Newbie

Having spent 25 years in the consumer research sector (finance, CPG, retail, tech, etc), I am used…

Read More
Read More

Reflections on PMRC 2025: The AI Train Left the Station… “Next Stop”

I have attended more than half of the PMRC conferences held over the past 16 years. Being a veteran…

Read More
Read More

10 Best Practices in Conducting Ethnography in Rare Disease Population

Rare disease patients face unique challenges that are often overlooked or misunderstood by those…

Read More
Read More

Building the Future: Why Qualitative Insights Will Thrive in the Age of AI

AI is transforming the way we collect and analyze qualitative data—but rather than replacing…

Read More
Read More

KJT Welcomes Katherine Ephlin as Research, Executive Vice President

KJT, a leader in strategic research insights, real-world evidence and medical communications for…

Read More
Read More

How AI Will Impact the Value of Qualitative Insights

The healthcare industry is experiencing a seismic shift in how market research is conducted and…

Read More
Read More

Navigating Complex Patient Experiences through Qualitative Research

In today’s complex healthcare landscape, understanding patient experiences is more crucial than…

Read More
Read More

Empathy, Integrity, and Mindfulness: The Values that Drive Innovation at KJT 

We are immensely proud of our journey from a nascent market research firm in 2007 to a recognized…

Let’s Take Research Further. Together.